A circRNA for the sustained expression of firefly luciferase
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Firefly Luciferase circRNA

Item No. 45064

Technical Information
Synonyms
  • FLuc Circular RNA
Emission
560 nm
Formulation
A liquid
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Lipid Nanoparticle Resource Center for Additional Tools & Resources
    EXPLORE NOW
    Product Description

    Firefly luciferase (FLuc) circular RNA (circRNA) encodes firefly luciferase, a protein originally isolated from the firefly P. pyralis, that catalyzes the ATP-dependent oxidation of the molecule luciferin (D-luciferin; Item Nos. 25836 | 14682 | 14681) resulting in chemiluminescence at a wavelength of approximately 560 nm.1 Exogenous circRNAs have increased stability and can produce sustained protein expression compared to mRNA.2 Firefly luciferase circRNA has been used as a reporter for the delivery of circRNA via lipid nanoparticles (LNPs).3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Baldwin, T.O. Firefly luciferase: The structure is known, but the mystery remains. Structure 4(3), 223-228 (1996).

    2. Wesselhoeft, R.A., Kowalski, P.S., and Anderson, D.G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9(1), 2629 (2018).

    3. Alshehry, Y., Liu, X., Zhang, Y., et alInvestigation of the impact of lipid nanoparticle compositions on the delivery and T cell response of circRNA vaccine. J. Control Release 381, 113617 (2025).